Purdue Pharma's patent for OxyContin expired Tuesday, opening up the opioid painkiller to generic competition, but authorities have raised concerns about what they call the potential for generic versions to be abused.

This ain’t your mother’s Olay. That’s essentially the message that the long-standing skin care brand is sending to women in their 20s with its new Fresh Effects collection that hit shelves in January with a new, innovative approach to in-store shelving. To learn more about this unprecedented launch for Olay, Drug Store News talked with Janine Miletic, associate marketing director for Olay Global.

The Food and Drug Administration has approved a contraceptive therapy made by Lupin Pharmaceuticals, the Indian drug maker said Friday.

The Food and Drug Administration is granting an expedited application process to a company that has developed a treatment for a condition related to Parkinson's disease, meaning that it can cancel a planned late-stage clinical trial, the company said.